Wong W, Li M. Response to the Letter to the Editor on "CNS Outcomes of Osimertinib Plus Chemotherapy in Patients with EGFR Mutation-Positive Lung Cancer Beyond Osimertinib Progression". Clin Lung Cancer 2025 Jun 26:S1525-7304(25)00143.
PMID: 40683813